- Published:
Toxicity of Halogenated Oxyquinolines in Dogs. A Clinical Study
I. A Survey of Cases
Toxiciteten av oxikinoliner hos hund. En klinisk studie
I. Kasuistik
Acta Veterinaria Scandinavica volume 14, pages 723–744 (1973)
Abstract
A survey of 100 cases of oxyquinoline poisoning in dogs is presented. The disease, characterized by hyperexcitability of the CNS with convulsions as well as heart and liver injury, runs an acute course. The mortality (euthanized dogs included) was 30 %. Case-history data showed that the oxyquinoline treatment which preceded the disease was given because the dog had incidental diarrhoea. In most cases the drugs were administered for only 1 day before the dog fell ill. The median time from the last dose to onset of symptoms was 12 hrs. Old dogs were affected more often than expected and also showed higher mortality than did young dogs.
Sammanfattning
En översikt av 100 fall av oxikinolinförgiftning hos hund presenteras. Sjukdomen som har ett akut förlopp karakteriseras bl. a. av ökad retbarhet i CNS samt myokard- och leverskador. Mortaliteten (avlivade hundar inkluderade) var 30 %. Enligt anamnetiska uppgifter hade oxikinolinbehandlingen, som föregick sjukdomen, utförts p. g.a. att hunden hade tillfällig diarré. I flertalet fall hade preparatet givits endast 1 dag innan hunden insjuknade. Medianen (avseende tiden från sista dosen till symtomens uppträdande) var 12 timmar. Gamla hundar insjuknade oftare och visade högre mortalitet än de yngre hundarna.
References
Bengtsson, K. & O. Vikrot: Retrograd amnesi efter broxikinolin. (Retrograde amnesia after broxyquinoline). Svenska Läk.-Tidn. 1972, 69, 14–16.
Berggren, L. & O. Hansson: Treating acrodermatitis enteropathica. Lancet 1966, 1, 52.
Berggren, L. & O. Hansson: Absorption of intestinal antiseptics derived from 8-hydroxyquinolines. Clin. Pharmacol. Ther. 1968, 9, 67–70.
Berggren, L., O. Hansson & I. Wahlberg: Läkemedelsbiverkan och tarmresorbtion av 3-hydroxykinolinpreparat. (Secondary effect and absorption from the intestine of 8-hydroxyquinoline drugs). Svenska Läk.-Tidn. 1968, 65, 3772–3773.
Christensen, F. & H. Dam: Kidney damage in hamsters receiving an artificial diet containing 5,7-dichloro-8-hydroxychinaldine. Acta Pharmacol. (Kbh.) 1961, 18, 249–254.
Cohn, H. D. & J. S. Harun: Letter to the Editor. J. Amer. med. Ass. 1972, 220, 276.
David, N. A., H. G. Johnstone, A. C. Reed & C. D. Leake: The treatment of amebiasis with iodochlorhydroxyquinoline (Vioform N.N.R.). J. Amer. med. Ass. 1933, 100, 1658–1661.
David, N. A., N. M. Phatak & F. B. Zener: Iodochiorhydroxyquinoline and diiodohydroxyquinoline: animal toxicity and absorption in man. Amer. J. trop. Med. 1944, 24, 29–33.
Domar, M. & L. Juhlin: Allergic dermatitis produced by oral clioquinol. Lancet 1967, 1, 1165–1166.
Etheridge, J. E., Jr. & G. E. Stewart: Treating acrodermatitis enteropathica. Lancet 1966, 1, 261–262.
Gholz, L. M. & W. L. Arons: Prophylaxis and therapy of amebiasis and shigellosis with iodochlorhydroxyquin. Amer. J. trop. Med. 1964, 13, 396–401.
Goodman, L. S. & A. Gilman: The Pharmacological Rasis of Therapeutics. 4th Ed. The Macmillan Company, New York 1971.
Griffith, B. M.: Intestopan, a 26-week oral toxicity study in dogs. Sandoz Ltd., Dept. Pharm Tox., March 28, 1969 (unpublished).
Hangartner, P.: Troubles nerveux observés chez le chien après absorbtion d’entérovioform Ciba. (Nervous symptoms observed in dogs after absorption of Enterovioform Ciba). Schweiz. Arch. Tierheilk. 1965, 107, 43–47.
Haskins, W. T. & G. W. Luttermoser: Urinary excretion of vioform and diodoquin in rabbits. J. Pharmacol, exp. Ther. 1953, 109, 201–205.
Hessle, L.-O.: Personal communication 1971.
Kaeser, H. E. & G. Scollo-Lavizzari: Akute zerebrale Störungen nach hohen Dosen eines Oxychinolinderivates. Acute cerebral disturbance after high doses of an oxyquinoline derivative). Dtsch. med. Wschr. 1970, 95, 394–397.
Kaeser, H. E. & R. Wüthrich: Zur Frage der Neurotoxizität der Oxychinoline. (On the possible neurotoxicity of oxyquinoline). Dtsch. med. Wschr. 1970, 95, 1685–1688.
Kjaersgaard, K.: Amnesia after clioquinol. Lancet 1971, 2, 1086.
Knight, A. A. & J. Miller: Comparative studies on the iodine absorption of Anayodin, Chiniofon, Diodoquin, and Vioform in man. Ann. intern. Med. 1949, 30, 1180–1187.
Lannek, B.: Toxicity of halogenated oxyquinolines in dogs. A clinical study. II. History, symptoms, laboratory findings, therapy and follow-up. To be published.
Lannek, B. & P. Lindberg: Toxicity of halogenated oxyquinolines in dogs. An experimental study. To be published.
Meier-Ruge, W.: Experimentelle Erzeugung von Veränderungen am distalen Tubulus der Niere durch halogenierte Chinolin- und Chinaldinderivate. (Experimental production of changes in the distal renal tubule by halogenated quinoline- and chinaldin-derivatives). Verh. dtsch. Ges. Path. 1963, 47, 356–361.
Meier-Ruge, W.: Untersuchungen über primäre Alterationen am distalen Nierentubulus der Ratte mit Störung des Haarnadelgegenstromsystems. (Studies of the primary changes of the distal renal tubule of the rat with disturbance of the hair-pin counter current system). Virchows Arch. path. Anat. 1964, 337, 470–482.
Müller, L. F.: Die Mexaformvergiftung des Hundes (Klinische Demonstration). (The mexaform poisoning in the dog. Clinical demonstration). Kleintier-Prax. 1967, 12, 51–52.
Palm, A.: Untersuchungen in der Chinolinreihe. X. Mitteilung: Dijod-verbindungen. (Investigations of the quinoline series. X. Communication: Diiodocombinations). Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 1932, 166, 176–185.
Püschner, H. & R. Fankhauser: Neuropathologische Befunde bei experimenteller Vioform-Vergiftung der weissen Maus. (Neurological symptoms after experimental Vioform poisoning in the white mouse). Schweiz. Arch. Tierheilk. 1969, 111, 371–379.
Remington, R. D. & M. A. Schork: Statistics with Applications to the Biological and Health Sciences. Prentice-Hall, Inc., Englewood Cliffs, New Jersey 1970.
Ritter, P. & M. J ermann: Vergleichende Untersuchungen über Resorption und Stoffwechsel einiger therapeutisch angewendeter 8-Hydroxychinoline. (Comparative study on the absorption and the metabolism of some 8-hydroxyquinolines for therapeutic use). Arzneimittel-Forsch. 1966, 16, 1647–1652.
Schantz, B. & B. Wikström: Suspected poisoning with oxyquinoline preparations in dogs. Svensk Vet.-T. 1965, 4, 106–107.
Silverman, D. N. & A. Leslie: Toxic effects of diodoquin. J. Amer. med. Ass. 1945, 128, 1080–1081.
Strandvik, B. & R. Zetterström: Amaurosis after broxyquinoline. Lancet 1968, 1, 922–923.
Tateishi, J., S. Kuroda, A. Saito & S. Otsuki: Myelo-optic neuropathy induced by clioquinol in animals. Lancet 1971, 2, 1263–1264.
Tenney, A. C.: The present concept of Entameba Histolytica infestation. Illinois med. J. 1936, 70, 145–148.
Author information
Authors and Affiliations
Additional information
Supported by grants from the Swedish Medical Research Council.
Rights and permissions
About this article
Cite this article
Lannek, B. Toxicity of Halogenated Oxyquinolines in Dogs. A Clinical Study. Acta Vet Scand 14, 723–744 (1973). https://doi.org/10.1186/BF03547401
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1186/BF03547401